Nearly one in ten adults in Great Britain have either recently used GLP-1 weight loss medications or are seriously considering doing so.
Pharmaceutical supply chains were not designed for that, especially for a cold chain product delivered on a weekly basis.
Their efficacy has driven enormous media interest, with many people sharing transformational experiences.
Check out the rest of the feature here
